Saudi Arabia Pharmaceutical Glass Packaging Market Size (2024 - 2029)

The Saudi Arabian pharmaceutical glass packaging market is poised for growth, driven by increasing demand from the pharmaceutical sector and the prevalent use of generic injectable medications. The inherent properties of glass, such as preventing gas infiltration and reducing medication contamination, enhance product stability and are expected to boost market size. Strict regulations in the healthcare industry, coupled with investments in packaging to extend product shelf life, further contribute to market expansion. Additionally, rising lifestyle diseases, strong brand loyalty for foreign medicines, and improved healthcare infrastructure are key factors influencing the market's growth trajectory. Despite challenges like supply chain disruptions from the COVID-19 pandemic and geopolitical tensions, the pharmaceutical sector's resilience and the growing need for packaging solutions continue to support the market's development.

Market Size of Saudi Arabia Pharmaceutical Glass Packaging Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Saudi Arabia Pharmaceutical Glass Packaging Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 4.32 %
Market Concentration High

Major Players

Saudi Arabia Pharmaceutical Glass Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Saudi Arabia Pharmaceutical Glass Packaging Market Analysis

The Saudi Arabian pharmaceutical glass packaging market is anticipated to register a CAGR of 4.32% over the forecast period. Growing demand from the pharmaceutical sector and widespread use of generic injectable medications are expected to drive market expansion.

  • Glass prevents gases like carbon dioxide and oxygen from getting into the main container, reducing the chance of medication contamination. Drug deterioration, including oxidation and hydrolysis, is less likely to occur when packaged in glass. Additionally, glass packaging helps to prevent volatile compounds from escaping, improving medicine stability. All of these factors are expected to increase product demand in the country.
  • Strict rules regarding drug delivery products have been established due to the rising relevance of biotech and cost-sensitive medications in the healthcare industry. Many companies in the pharmaceutical glass manufacturing industry are investing in pharmaceuticals because they are concentrating on packaging, which is intended to lengthen the shelf life of a product.
  • For instance, in June 2021, GlaxoSmithKline and Saudi Chemical Company Holding (SCCH) made a contract to produce pharmaceuticals in Saudi Arabia. AJA Pharmaceutical Industries, a division of SCCH, will collaborate with GlaxoSmithKline Consumer Healthcare Saudi in a five-year, SAR 100 million (USD 26.66 million) manufacturing agreement. Additionally, the new alliance would contribute to expanding Saudi Arabian jobs in the country's pharmaceutical industry.
  • Further, in Saudi Arabia, rising lifestyle diseases and strong brand loyalty for foreign medicines are projected to drive up pharmaceutical demand throughout the forecast period. The expansion of the Saudi pharmaceuticals sector is also fueled by rising per capita income, a growing healthcare infrastructure, and greater penetration of health insurance companies in the Kingdom.
  • Moreover, the rise in non-communicable diseases and improved healthcare facilities are primarily responsible for Saudi Arabia's fast growth in pharmaceutical packaging demand. MNCs dominate Saudi Arabia's pharmaceutical packaging industry with a significant market share. The market's rise is anticipated to be aided by rising healthcare spending and increased health consciousness.
  • The COVID-19 pandemic caused supply chain disruptions and a lack of raw materials in several industries, but it had little impact on the pharmaceutical sector. Pharmaceutical businesses were exempt from shutdown restrictions because they are vital to the community. Companies in the industry met the growing demand for packaging from pharmaceutical items connected to COVID-19, by automating their processes and using the fewest possible human resources to prevent the spread of the virus. Further, the Russia-Ukraine war has an impact on the overall packaging ecosystem.

Saudi Arabia Pharmaceutical Glass Packaging Industry Segmentation

Pharmaceutical preparations can be safely stored in sanitized glass containers with a reliable closure mechanism. The containers are made with a focus on facilitating the ease of using the contents and are suitable for the preparation's intended purpose. The study on the Saudi Arabian pharmaceutical glass packaging market tracks the revenue of various glass product types primarily sold for pharmaceutical packaging applications. The study is focused on consumption trends and demand estimates across Saudi Arabia.

The Saudi Arabia pharmaceutical glass packaging market is segmented by glass type (Type I, Type II, and Type III), product type (bottles and containers, vials, ampoules, cartridges and syringes, and other product types), and application type (branded, biologics, and generic). the market sizes and forecasts are provided in terms of value (USD million) for all the above segments.

By Glass Type
Type I
Type II
Type III
By Product Type
Bottles and Containers
Vials
Ampoules
Cartridges and Syringes
Other Product Types
By Application Type
Branded
Biological
Generic
Need A Different Region Or Segment?
Customize Now

Saudi Arabia Pharmaceutical Glass Packaging Market Size Summary

The Saudi Arabian pharmaceutical glass packaging market is poised for growth, driven by increasing demand from the pharmaceutical sector and the prevalent use of generic injectable medications. Glass packaging is favored for its ability to prevent contamination and preserve the stability of medications by blocking gases and volatile compounds. The market is further bolstered by stringent regulations surrounding drug delivery products, which have prompted pharmaceutical glass manufacturers to invest in packaging solutions that extend product shelf life. The collaboration between GlaxoSmithKline and Saudi Chemical Company Holding to produce pharmaceuticals locally exemplifies the strategic investments being made to enhance the sector. Additionally, the rise in lifestyle diseases and brand loyalty for foreign medicines is expected to sustain the demand for pharmaceutical products, supported by improved healthcare infrastructure and increased health insurance penetration in the Kingdom.

Saudi Arabia's pharmaceutical glass packaging market is also influenced by the country's economic position within the Gulf Cooperation Council (GCC) and its ambitious Vision 2030 plan, which aims to boost local production of pharmaceuticals. The market is characterized by significant imports of pharmaceutical products and glass containers, with major players like Becton, Dickinson and Company, and Corning Incorporated leading innovations in packaging technology. The market's expansion is supported by strategic partnerships and investments, such as the collaboration between West Pharmaceutical Services Inc. and Corning Incorporated to enhance injectable drug packaging. The establishment of new manufacturing facilities, like the one in Qassim by Saudi Pharmaceutical Industries & Medical Appliances Corporation, further underscores the growth potential for glass packaging companies in the region.

Explore More

Saudi Arabia Pharmaceutical Glass Packaging Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Industry Value Chain Analysis

    3. 1.3 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.3.1 Bargaining Power of Suppliers

      2. 1.3.2 Bargaining Power of Consumers

      3. 1.3.3 Threat of New Entrants

      4. 1.3.4 Threat of Substitute Products

      5. 1.3.5 Intensity of Competitive Rivalry

    4. 1.4 Assessment of the Impact of COVID-19 on the Market

    5. 1.5 Overview of the Global Pharmaceutical Glass Packaging Market

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Glass Type

      1. 2.1.1 Type I

      2. 2.1.2 Type II

      3. 2.1.3 Type III

    2. 2.2 By Product Type

      1. 2.2.1 Bottles and Containers

      2. 2.2.2 Vials

      3. 2.2.3 Ampoules

      4. 2.2.4 Cartridges and Syringes

      5. 2.2.5 Other Product Types

    3. 2.3 By Application Type

      1. 2.3.1 Branded

      2. 2.3.2 Biological

      3. 2.3.3 Generic

Saudi Arabia Pharmaceutical Glass Packaging Market Size FAQs

The Saudi Arabia Pharmaceutical Glass Packaging Market is projected to register a CAGR of 4.32% during the forecast period (2024-2029)

Becton, Dickinson and Company, DWK Life Sciences GmbH, GlaxoSmithKline plc, Corning Incorporated and Pharmaceutical Solutions Industry Ltd are the major companies operating in the Saudi Arabia Pharmaceutical Glass Packaging Market.

Saudi Arabia Pharmaceutical Glass Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)